Bromide

Bromide

SCHEMBL1868689

Br.O=C(c1cc(CCBr)c2oc(N3CCOCC3)cc(=O)c2c1)N1CCCC1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PIK3CB P42338 20/20 0.55
▸ PIK3CD O00329 10/20 0.55
▸ PIK3CA P42336 10/20 0.55
▸ PIK3CG P48736 10/20 0.55
▸ MTOR P42345 1/20 0.50
▸ KCNH2 Q12809 1/20 0.50
▸ SPHK1 Q9NYA1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1863568 0.99 PIK3CB (0.56) PIK3CBPIK3CDPIK3CAPIK3CGMTOR
SCHEMBL1869817 0.90 PIK3CB (0.57) PIK3CBPIK3CDPIK3CAPIK3CGMTOR
Bromide SCHEMBL1868104 0.84 PIK3CB (0.68) PIK3CBPIK3CDPIK3CAPIK3CGKCNH2
SCHEMBL1871780 0.83 PIK3CB (0.69) PIK3CBPIK3CDPIK3CAPIK3CGKCNH2
SCHEMBL1866542 0.83 PIK3CB (0.52) PIK3CBPIK3CDPIK3CAPIK3CG
Bromide SCHEMBL1639537 0.81 PIK3CB (0.68) PIK3CBPIK3CDPIK3CAPIK3CG
SCHEMBL1864101 0.81 PIK3CB (0.68) PIK3CBPIK3CDPIK3CAPIK3CGMTOR
SCHEMBL1868654 0.80 PIK3CB (0.69) PIK3CBPIK3CDPIK3CAPIK3CGKCNH2
Bromide SCHEMBL1872307 0.80 PIK3CB (0.59) PIK3CBPIK3CDPIK3CAPIK3CGKCNH2
SCHEMBL1639150 0.80 PIK3CB (0.69) PIK3CBPIK3CDPIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493870-A1 CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY AstraZeneca AB (SE) 2012-09-05 — — EP disclosed
WO-2011051704-A1 CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY ASTRAZENECA AB (SE) 2011-05-05 — — WO disclosed
Send feedback